BioKuris

Skip to content

CHECKED

Companies Insolvencies Sectors Watchlist Alerts API

Sign in

BioKuris

Herstal ·KBO/BCE: BE 0769.454.379

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Badge

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Answers from Checked AI. Not legal advice.

Metric	This company	Sector median	Position in the sector
Solvency	18.0%	46.8%	better than 32% of 79 sector peers
Net result	€-1.68M	€17k	better than 7% of 78 sector peers
Equity	€1.05M	€78k	better than 85% of 79 sector peers
Gross operating margin	€-512k	€49k	better than 5% of 74 sector peers
Total assets	€5.85M	€238k	better than 90% of 79 sector peers

Fiscal year	2025
Revenue	€700k
EBITDA	€-571k
Net profit	€-1.68M
Cash flow	€-608k
Staff costs	€59k
Income taxes	-
Dividends	-
Total assets	€5.85M
Equity	€1.05M
Debt	€4.79M
of which ≤ 1y	€1.78M
of which > 1y	€3.01M
Working capital	€-877k
Employees (FTE)	1.0

	2025
Current ratio	0.51
Quick ratio	0.51
Working capital ratio	-15.0%
Solvency	18.0%
Debt / equity	4.56
Long-term debt ratio	2.87
Interest coverage	-15.41
Gross margin	-225.5%
Net margin	-239.6%
ROA	-28.7%
ROE	-159.7%
EBITDA margin	-81.5%
Days sales outstanding	57d
Days payable outstanding	114d
Inventory turnover	-
Days inventory (DSI)	-

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€5.85M
Fixed assets	21/28	€4.94M
Formation expenses	20	€957
Intangible fixed assets	21	€4.94M
Current assets	29/58	€904k
Amounts receivable within one year	40/41	€681k
Cash & bank	54/58	€223k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€5.85M
Equity	10/15	€1.05M
Contributions / capital	10/11	€1.52M
Accumulated profits (losses)	14	€-2.63M
Amounts payable	17/49	€4.79M
Amounts payable after one year	17	€3.01M
Amounts payable within one year	42/48	€1.78M
Trade debts payable within one year	44	€712k
Income statement
Turnover	70	€700k
Gross operating margin	9900	€-512k
Operating result	9901	€-1.64M
Financial income	75	€63
Financial charges	65	€37k
Result before taxes	9903	€-1.68M
Net result for the period	9904	€-1.68M
Result to be appropriated	9905	€-1.68M

NACE primary	Speur- en ontwikkelingswerk op biotechnologisch gebied(72101)
Legal form	Public limited company(014)
Incorporation	08-06-2021
Status	Active
Postal code	4040

Summary

Conclusion

Bankruptcy probability (12 mo)

Signals

Trust signals

Administrative Flags

Financials

Annual accounts & ratios

Health barometer

Directors

Directors & mandates

Statutory auditor

Insolvency mandates

Legal Structure

Structure & network

Locations & real estate

Registered office

Establishment units

Real-estate footprint

Analysis

Snowflake analysis

Ask AI about this company

AI due-diligence brief

Credit advice

Similar

Similar companies

Company registry

Company registry (CBE)